ArticleActa neuropathologica communications2019
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).
Erratum issuedAbstract readLetter
In one paragraph
Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome.Acta neuropathologica communications · 2025Article
- MYCN as an oncogene in pediatric brain tumors.Frontiers in oncology · 2025Review
- Molecular and Pathological Features of Paediatric High-Grade Gliomas.International journal of molecular sciences · 2024Review
- Recent updates in pediatric diffuse glioma classification: insights and conclusions from the WHO 5Journal of medicine and life · 2024Review
- The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas.Biomedicines · 2024Review
- Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?Frontiers in molecular neuroscience · 2024Review
- Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.Nature communications · 2023Article
- Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status.Acta neuropathologica communications · 2023Article
- Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity.Brain tumor pathology · 2023Article
- Adult-type and Pediatric-type Diffuse Gliomas : What the Neuroradiologist Should Know.Clinical neuroradiology · 2023Review
- Newly Recognized CNS Tumors in the 2021 World Health Organization Classification: Imaging Overview with Histopathologic and Genetic Correlation.AJNR. American journal of neuroradiology · 2023Review
- Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.Pediatric radiology · 2023Review
- Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.Acta neuropathologica communications · 2023Article
- Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.Frontiers in immunology · 2023Review
- Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma.Frontiers in pharmacology · 2023Review
- Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta neuropathologica · 2023Article
- Review
- 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.Neuroradiology · 2022Review
- Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series.Genes · 2022Article
- EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.Acta neuropathologica communications · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
12 authors.
A Tauziède-EspariatDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital 1, rue Cabanis, 75014, Paris, France. a.tauziede-espariat@ghu-paris.fr.
M-A DebilyUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, University of Paris-Sud, University of Paris-Saclay, 94805, Villejuif cedex, France.
D CastelUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, University of Paris-Sud, University of Paris-Saclay, 94805, Villejuif cedex, France.
J GrillUMR8203, Vectorologie et thérapeutiques anticancéreuses, CNRS, Gustave Roussy, University of Paris-Sud, University of Paris-Saclay, 94805, Villejuif cedex, France.
S PugetDepartment of Pediatric Neurosurgery, Necker Hospital, APHP, Universite Paris Descartes, Sorbonne Paris Cite, 75015, Paris, France.
M SabelDepartment of Pediatric Oncology, Childhood Cancer Centre Queen Silvia Children's Hospital, Sahlgrenska University hospital, University of Gothenburg, Gothenburg, Sweden.
K BlomgrenDepartment of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
A GaretonDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital 1, rue Cabanis, 75014, Paris, France.
V Dangouloff-RosDepartment of Radiology, Necker Hospital, APHP, Universite Paris Descartes, Sorbonne Paris Cite, 75015, Paris, France.
E LechaptDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital 1, rue Cabanis, 75014, Paris, France.
N BoddaertDepartment of Radiology, Necker Hospital, APHP, Universite Paris Descartes, Sorbonne Paris Cite, 75015, Paris, France.
P VarletDepartment of Neuropathology, GHU Paris-Neurosciences, Sainte-Anne Hospital 1, rue Cabanis, 75014, Paris, France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Brain Stem NeoplasmsChildChild, PreschoolDiagnosis, DifferentialFemaleGene AmplificationGliomaHumansInfantJumonji Domain-Containing Histone DemethylasesMaleN-Myc Proto-Oncogene ProteinNucleic Acid Amplification TechniquesPonsJumonji Domain-Containing Histone DemethylasesKDM6B protein, humanMYCN protein, humanN-Myc Proto-Oncogene Protein
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.